Update: 31.08.2022
Last week: 33 week 2022 (15.08.2022 - 21.08.2022)
Last full month: July 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 99 980 | 14.6% | 3.9% | 0.1 | 19 910 228 | 15.0% | 3.8% | 0.1 | 12.3% |
| MoM | 467 964 | -5.9% | 6.2% | 0.9 | 91 081 370 | -7.9% | 5.7% | 0.8 | -19.4% |
| YTD | 6 769 784 | 10.6% | 5.9% | 0.1 | 1 337 617 352 | 30.4% | 5.6% | 0.4 | 8.9% |
| MAT | 13 917 618 | 33.7% | 6.4% | 1.2 | 2 602 506 790 | 56.3% | 6.0% | 1.3 | 8.7% |
| DEXALGIN | |||||||||
| WoW | 17 983 | 5.0% | 0.4% | 0 | 8 400 315 | 5.7% | 1.1% | 0 | 5.0% |
| MoM | 117 256 | -6.4% | 0.7% | 0 | 50 089 782 | -6.6% | 1.9% | 0 | -4.1% |
| YTD | 1 224 760 | 18.4% | 0.8% | 0.1 | 510 737 494 | 30.0% | 2.0% | 0.2 | 4.0% |
| MAT | 2 028 894 | 9.3% | 0.8% | 0 | 818 668 492 | 18.1% | 2.1% | 0.1 | 2.7% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 57 575 | 0.1% | 46.3% | -0.7 | 30 355 341 | -0.4% | 52.7% | -0.2 | 1.7% |
| MoM | 318 430 | -5.2% | 55.8% | -1 | 161 646 972 | -6.1% | 61.2% | -1.4 | -3.6% |
| YTD | 3 190 615 | 0.1% | 57.6% | -8.9 | 1 613 377 305 | 12.5% | 63.1% | -7.1 | 15.6% |
| MAT | 5 285 759 | 5.2% | 60.3% | -5.7 | 2 604 367 492 | 19.0% | 65.8% | -4.3 | 15.2% |
| ESPUMISAN BABY | |||||||||
| WoW | 23 372 | 1.7% | 34.4% | -0.6 | 15 053 469 | 1.7% | 47.4% | -0.6 | 3.4% |
| MoM | 100 138 | -6.9% | 37.7% | -1.4 | 63 444 221 | -5.9% | 50.6% | -1.3 | -3.4% |
| YTD | 971 730 | -8.2% | 38.6% | -3.4 | 600 816 958 | -2.0% | 51.9% | -4.9 | -0.1% |
| MAT | 1 576 888 | -9.4% | 39.2% | -2.1 | 959 450 008 | -1.3% | 53.0% | -2.3 | -4.6% |
| FASTUM | |||||||||
| WoW | 14 719 | 4.9% | 0.9% | 0 | 8 070 715 | 5.5% | 2.1% | 0 | 4.5% |
| MoM | 71 372 | -12.0% | 1.1% | 0 | 37 717 439 | -10.8% | 2.4% | 0 | -14.1% |
| YTD | 736 008 | -16.5% | 1.2% | -0.3 | 375 587 419 | -7.2% | 2.6% | -0.5 | 2.0% |
| MAT | 1 239 769 | -14.8% | 1.3% | -0.2 | 610 938 028 | -6.5% | 2.8% | -0.4 | 1.2% |
| IODOMARIN | |||||||||
| WoW | 58 135 | 8.2% | 22.1% | 1.1 | 11 099 686 | 7.5% | 9.8% | 0.3 | 2.7% |
| MoM | 215 761 | -8.7% | 21.2% | 0.4 | 43 032 457 | -12.6% | 9.6% | -0.2 | -10.6% |
| YTD | 1 911 223 | 5.9% | 18.8% | -0.1 | 384 242 920 | 13.1% | 8.6% | 0 | 6.7% |
| MAT | 3 273 050 | 22.8% | 20.4% | 2.6 | 636 908 925 | 24.3% | 9.3% | 1 | 7.2% |
| LIOTON | |||||||||
| WoW | 21 925 | 5.9% | 2.1% | 0.1 | 23 625 042 | 6.9% | 4.4% | 0.3 | 0.6% |
| MoM | 101 978 | -9.4% | 2.4% | 0 | 105 289 953 | -11.3% | 4.7% | 0 | -9.5% |
| YTD | 929 427 | -19.0% | 2.4% | -0.4 | 944 644 249 | 2.0% | 4.9% | -0.7 | -5.8% |
| MAT | 1 474 255 | -15.3% | 2.5% | -0.3 | 1 421 163 304 | 3.7% | 5.1% | -0.5 | -5.9% |
| MEZYM | |||||||||
| WoW | 217 801 | 1.4% | 19.8% | -0.2 | 32 847 959 | 0.8% | 14.0% | -0.3 | 2.4% |
| MoM | 1 268 153 | -0.1% | 27.4% | 1 | 195 815 455 | 1.4% | 19.8% | 1.3 | -3.9% |
| YTD | 13 100 933 | 14.0% | 28.7% | 2.1 | 2 004 892 660 | 23.5% | 20.6% | 0.6 | 5.8% |
| MAT | 22 371 319 | 20.2% | 30.3% | 3.1 | 3 289 659 302 | 26.3% | 21.9% | 1.3 | 7.8% |
| MIG 400 | |||||||||
| WoW | 140 651 | 2.2% | 2.9% | -0.1 | 16 754 862 | 2.0% | 2.2% | 0 | 5.0% |
| MoM | 595 570 | -7.5% | 3.6% | -0.1 | 69 690 474 | -8.5% | 2.6% | -0.1 | -4.1% |
| YTD | 5 679 686 | -4.2% | 3.5% | -0.3 | 666 552 654 | -0.6% | 2.6% | -0.4 | 4.0% |
| MAT | 9 642 306 | 4.5% | 3.6% | 0.1 | 1 112 658 248 | 7.9% | 2.8% | -0.1 | 2.7% |
| PROSTAMOL | |||||||||
| WoW | 19 742 | 3.0% | 15.2% | -0.4 | 27 775 975 | 3.7% | 16.0% | -0.3 | 6.0% |
| MoM | 93 730 | -9.6% | 17.9% | -0.4 | 129 382 622 | -10.4% | 18.8% | -0.8 | -7.6% |
| YTD | 1 099 600 | -16.7% | 20.2% | -4.7 | 1 543 589 340 | -6.4% | 21.6% | -5.8 | 2.7% |
| MAT | 1 919 984 | -8.8% | 21.7% | -2.8 | 2 595 286 707 | -0.3% | 23.1% | -3.7 | 2.9% |
| RESPERO MYRTOL | |||||||||
| WoW | 15 721 | 13.9% | 9.1% | 0 | 7 413 010 | 14.0% | 9.3% | 0.1 | 13.7% |
| MoM | 44 155 | -22.5% | 7.9% | 0.4 | 20 644 482 | -23.6% | 7.8% | 0.5 | -26.4% |
| YTD | 795 577 | 185.9% | 9.1% | 5.6 | 370 673 964 | 177.3% | 8.8% | 4.9 | 9.1% |
| MAT | 1 264 069 | 122.6% | 8.2% | 4.1 | 581 875 211 | 111.5% | 8.0% | 3.3 | 11.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 769 784 | 10.6% | 5.9% | 0.1 | 1 337 617 352 | 30.4% | 5.6% | 0.4 | 8.9% |
| DEXALGIN | 1 224 760 | 18.4% | 0.8% | 0.1 | 510 737 494 | 30.0% | 2.0% | 0.2 | 4.0% |
| ESPUMISAN (ADULTS) | 3 190 615 | 0.1% | 57.6% | -8.9 | 1 613 377 305 | 12.5% | 63.1% | -7.1 | 15.6% |
| ESPUMISAN BABY | 971 730 | -8.2% | 38.6% | -3.4 | 600 816 958 | -2.0% | 51.9% | -4.9 | -0.1% |
| FASTUM | 736 008 | -16.5% | 1.2% | -0.3 | 375 587 419 | -7.2% | 2.6% | -0.5 | 2.0% |
| IODOMARIN | 1 911 223 | 5.9% | 18.8% | -0.1 | 384 242 920 | 13.1% | 8.6% | 0 | 6.7% |
| LIOTON | 929 427 | -19.0% | 2.4% | -0.4 | 944 644 249 | 2.0% | 4.9% | -0.7 | -5.8% |
| MEZYM | 13 100 933 | 14.0% | 28.7% | 2.1 | 2 004 892 660 | 23.5% | 20.6% | 0.6 | 5.8% |
| MIG 400 | 5 679 686 | -4.2% | 3.5% | -0.3 | 666 552 654 | -0.6% | 2.6% | -0.4 | 4.0% |
| PROSTAMOL | 1 099 600 | -16.7% | 20.2% | -4.7 | 1 543 589 340 | -6.4% | 21.6% | -5.8 | 2.7% |
| RESPERO MYRTOL | 795 577 | 185.9% | 9.1% | 5.6 | 370 673 964 | 177.3% | 8.8% | 4.9 | 9.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 13 917 618 | 33.7% | 6.4% | 1.2 | 2 602 506 790 | 56.3% | 6.0% | 1.3 | 8.7% |
| DEXALGIN | 2 028 894 | 9.3% | 0.8% | 0 | 818 668 492 | 18.1% | 2.1% | 0.1 | 2.7% |
| ESPUMISAN (ADULTS) | 5 285 759 | 5.2% | 60.3% | -5.7 | 2 604 367 492 | 19.0% | 65.8% | -4.3 | 15.2% |
| ESPUMISAN BABY | 1 576 888 | -9.4% | 39.2% | -2.1 | 959 450 008 | -1.3% | 53.0% | -2.3 | -4.6% |
| FASTUM | 1 239 769 | -14.8% | 1.3% | -0.2 | 610 938 028 | -6.5% | 2.8% | -0.4 | 1.2% |
| IODOMARIN | 3 273 050 | 22.8% | 20.4% | 2.6 | 636 908 925 | 24.3% | 9.3% | 1 | 7.2% |
| LIOTON | 1 474 255 | -15.3% | 2.5% | -0.3 | 1 421 163 304 | 3.7% | 5.1% | -0.5 | -5.9% |
| MEZYM | 22 371 319 | 20.2% | 30.3% | 3.1 | 3 289 659 302 | 26.3% | 21.9% | 1.3 | 7.8% |
| MIG 400 | 9 642 306 | 4.5% | 3.6% | 0.1 | 1 112 658 248 | 7.9% | 2.8% | -0.1 | 2.7% |
| PROSTAMOL | 1 919 984 | -8.8% | 21.7% | -2.8 | 2 595 286 707 | -0.3% | 23.1% | -3.7 | 2.9% |
| RESPERO MYRTOL | 1 264 069 | 122.6% | 8.2% | 4.1 | 581 875 211 | 111.5% | 8.0% | 3.3 | 11.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 99 980 | 14.6% | 3.9% | 0.1 | 19 910 228 | 15.0% | 3.8% | 0.1 | 12.3% |
| DEXALGIN | 17 983 | 5.0% | 0.4% | 0 | 8 400 315 | 5.7% | 1.1% | 0 | 5.0% |
| ESPUMISAN (ADULTS) | 57 575 | 0.1% | 46.3% | -0.7 | 30 355 341 | -0.4% | 52.7% | -0.2 | 1.7% |
| ESPUMISAN BABY | 23 372 | 1.7% | 34.4% | -0.6 | 15 053 469 | 1.7% | 47.4% | -0.6 | 3.4% |
| FASTUM | 14 719 | 4.9% | 0.9% | 0 | 8 070 715 | 5.5% | 2.1% | 0 | 4.5% |
| IODOMARIN | 58 135 | 8.2% | 22.1% | 1.1 | 11 099 686 | 7.5% | 9.8% | 0.3 | 2.7% |
| LIOTON | 21 925 | 5.9% | 2.1% | 0.1 | 23 625 042 | 6.9% | 4.4% | 0.3 | 0.6% |
| MEZYM | 217 801 | 1.4% | 19.8% | -0.2 | 32 847 959 | 0.8% | 14.0% | -0.3 | 2.4% |
| MIG 400 | 140 651 | 2.2% | 2.9% | -0.1 | 16 754 862 | 2.0% | 2.2% | 0 | 5.0% |
| PROSTAMOL | 19 742 | 3.0% | 15.2% | -0.4 | 27 775 975 | 3.7% | 16.0% | -0.3 | 6.0% |
| RESPERO MYRTOL | 15 721 | 13.9% | 9.1% | 0 | 7 413 010 | 14.0% | 9.3% | 0.1 | 13.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 467 964 | -5.9% | 6.2% | 0.9 | 91 081 370 | -7.9% | 5.7% | 0.8 | -19.4% |
| DEXALGIN | 117 256 | -6.4% | 0.7% | 0 | 50 089 782 | -6.6% | 1.9% | 0 | -4.1% |
| ESPUMISAN (ADULTS) | 318 430 | -5.2% | 55.8% | -1 | 161 646 972 | -6.1% | 61.2% | -1.4 | -3.6% |
| ESPUMISAN BABY | 100 138 | -6.9% | 37.7% | -1.4 | 63 444 221 | -5.9% | 50.6% | -1.3 | -3.4% |
| FASTUM | 71 372 | -12.0% | 1.1% | 0 | 37 717 439 | -10.8% | 2.4% | 0 | -14.1% |
| IODOMARIN | 215 761 | -8.7% | 21.2% | 0.4 | 43 032 457 | -12.6% | 9.6% | -0.2 | -10.6% |
| LIOTON | 101 978 | -9.4% | 2.4% | 0 | 105 289 953 | -11.3% | 4.7% | 0 | -9.5% |
| MEZYM | 1 268 153 | -0.1% | 27.4% | 1 | 195 815 455 | 1.4% | 19.8% | 1.3 | -3.9% |
| MIG 400 | 595 570 | -7.5% | 3.6% | -0.1 | 69 690 474 | -8.5% | 2.6% | -0.1 | -4.1% |
| PROSTAMOL | 93 730 | -9.6% | 17.9% | -0.4 | 129 382 622 | -10.4% | 18.8% | -0.8 | -7.6% |
| RESPERO MYRTOL | 44 155 | -22.5% | 7.9% | 0.4 | 20 644 482 | -23.6% | 7.8% | 0.5 | -26.4% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs